RSC Pfizer Partnership
As Tony Wood, Vice President, Head of Chemistry and Exploratory Medicinal Sciences, PGRD, Sandwich explains "It's not just about the stream of graduates, it's about the nature of the training and their attitude to future learning and problem solving that is important".
Simon Campbell, Chair of the Fundraising Campaign and Former RSC President said "I am delighted that Pfizer and the RSC are working together to meet educational challenges of fundamental importance to the UK's future international competitiveness and I very much appreciate the major investment the Company is making in the next generation of innovative scientists."
Related Links
Pfizer Inc
The world's largest research-based pharmaceutical company, discovers, develops, manufactures and markets prescription medicines in 11 therapeutic areas including oncology, cardiovascular, pain, neuroscience and infectious diseases, including HIV/AIDS. Pfizer is also the world's largest animal health company. Pfizer Inc employs approximately 90,000 colleagues worldwide, all of whom are devoted to working for a healthier world. Pfizer conducts more biomedical research than any other organisation, and has 12,000 professionals working in six major R&D sites worldwide, including Sandwich in Kent. Pfizer's annual UK R&D investment is more than £550 million - more than £10 million a week.
External links will open in a new browser window
Contact and Further Information
Clare Viney
Manager, Corporate Relations
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, CB4 0WF
Tel: +44 (0) 1223 432267
Fax: +44 (0) 1223 426594
